Preparation, characterization and immunogenicity of HIV-1 related high-mannose oligosaccharides-CRM197 glycoconjugates

Glycoconjugate Journal

Volumn 27, Issue 5, 2010, Pages 501-513

  Kabanova, Anna ^a,b   Adamo, Roberto ^a   Proietti, Daniela ^a   Berti, Francesco ^a   Tontini, Marta ^a   Rappuoli, Rino ^a   Costantino, Paolo ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Glycoconjugate; High mannose; HIV; PAMAM; Vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G ANTIBODY; MANNOSE OLIGOSACCHARIDE DIPHTHERIA TOXOID CRM197 GLYCOCONJUGATE; MONOCLONAL ANTIBODY 2G12; POLYAMIDOAMINE; RECOMBINANT GLYCOPROTEIN GP 120; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG DESIGN; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOCHEMISTRY; IMMUNOGENICITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VIRUS ENTRY;

BACTERIAL PROTEINS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; GLYCOCONJUGATES; HIV ANTIGENS; HIV-1; HUMANS; MALE; MANNANS; MOLECULAR SEQUENCE DATA;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77955582586     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-010-9295-0     Document Type: Article

References (43)

1. WHO data, as of 2007: www.who.int/hiv/topics/mdg/info/en/index.html
2. PD Kwong ML Doyle DJ Casper C Cicala SA Leavitt S Majeed TD Steenbeke M Venturi I Chaiken M Fung H Katinger PW Parren J Robinson D Van Ryk L Wang DR Burton E Freire R Wyatt J Sodroski WA Hendrickson J Arthos 2002 HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites Nature 420 678 682 10.1038/nature01188 1:CAS:528:DC%2BD38XpsVSitbo%3D 12478295 (Pubitemid 36764500)
3. R Pantophlet DR Burton 2006 GP120: target for neutralizing HIV-1 antibodies Annu. Rev. Immunol. 24 739 769 10.1146/annurev.immunol.24.021605. 090557 1:CAS:528:DC%2BD28XkvFSqtbw%3D 16551265
4. X Wei JM Decker S Wang H Hui JC Kappes X Wu JF Salazar-Gonzalez MG Salazar JM Kilby MS Saag NL Komarova MA Nowak BH Hahn PD Kwong GM Shaw 2003 Antibody neutralization and escape by HIV-1 Nature 422 307 312 10.1038/nature01470 1:CAS:528:DC%2BD3sXitFKmurY%3D 12646921 (Pubitemid 36378357)
5. DR Burton RL Stanfield IA Wilson 2005 Antibody vs. HIV in a clash of evolutionary titans Proc. Natl. Acad. Sci. U.S.A. 102 14943 14948 10.1073/pnas.0505126102 1:CAS:528:DC%2BD2MXhtFGqtLfF 16219699 (Pubitemid 41513316)
6. DA Calarese CN Scanlan MB Zwick S Deechongkit Y Mimura R Kunert P Zhu MR Wormald RL Stanfield KH Roux JW Kelly PM Rudd RA Dwek H Katinger DR Burton IA Wilson 2003 Antibody domain exchange is an immunological solution to carbohydrate cluster recognition Science 300 2065 2071 10.1126/science.1083182 1:CAS:528:DC%2BD3sXkvVOrsLk%3D 12829775 (Pubitemid 36760127)
7. DR Burton RC Desrosiers RW Doms WC Koff PD Kwong JP Moore GJ Nabel J Sodroski IA Wilson RT Wyatt 2004 HIV vaccine design and the neutralizing antibody problem Nat. Immunol. 5 233 236 10.1038/ni0304-233 1:CAS:528: DC%2BD2cXhsFeit78%3D 14985706 (Pubitemid 38332116)
8. DA Calarese HK Lee CY Huang MD Best RD Astronomo RL Stanfield H Katinger DR Burton CH Wong IA Wilson 2005 Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12 Proc. Natl. Acad. Sci. U.S.A. 102 13372 13377 10.1073/pnas.0505763102 1:CAS:528:DC%2BD2MXhtVygsbnP 16174734 (Pubitemid 41420854)
9. CN Scanlan R Pantophlet MR Wormald E Ollmann Saphire R Stanfield IA Wilson H Katinger RA Dwek PM Rudd DR Burton 2002 The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1->2 mannose residues on the outer face of gp120 J. Virol. 76 7306 7321 10.1128/JVI.76.14.7306-7321.2002 1:CAS:528:DC%2BD38XltVylsLo%3D 12072529
10. EW Adams DM Ratner HR Bokesch JB McMahon BR O'Keefe PH Seeberger 2004 Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions Chem. Biol. 11 875 881 10.1016/j.chembiol.2004.04.010 1:CAS:528:DC%2BD2cXlt1Sjs7o%3D 15217620 (Pubitemid 38836903)
11. HK Lee CN Scanlan CY Huang AY Chang DA Calarese RA Dwek PM Rudd DR Burton IA Wilson CH Wong 2004 Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody Angew. Chem. Int. Ed Engl. 43 1000 1003 10.1002/anie.200353105 1:CAS:528:DC%2BD2cXhslKksLg%3D 14966891 (Pubitemid 39258001)
12. LX Wang J Ni S Singh H Li 2004 Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design Chem. Biol. 11 127 134 15113002
13. IJ Krauss JG Joyce AC Finnefrock HC Song VY Dudkin X Geng JD Warren M Chastain JW Shiver SJ Danishefsky 2007 Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody J. Am. Chem. Soc. 129 11042 11044 10.1021/ja074804r 1:CAS:528:DC%2BD2sXpt1WjtLk%3D 17711286 (Pubitemid 47435706)
14. J Wang H Li G Zou LX Wang 2007 Novel template-assembled oligosaccharide clusters as epitope mimics for HIV-neutralizing antibody 2G12. Design, synthesis, and antibody binding study Org. Biomol. Chem. 5 1529 1540 10.1039/b702961f 1:CAS:528:DC%2BD2sXmsV2jtLg%3D 17571181 (Pubitemid 46959421)
15. SK Wang PH Liang RD Astronomo TL Hsu SL Hsieh DR Burton CH Wong 2008 Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN Proc. Natl. Acad. Sci. U.S.A. 105 3690 3695 10.1073/pnas.0712326105 1:CAS:528:DC%2BD1cXjs1Oit7s%3D 18310320 (Pubitemid 351723459)
16. J Ni H Song Y Wang NM Stamatos LX Wang 2006 Toward a carbohydrate-based HIV-1 vaccine: synthesis and immunological studies of oligomannose-containing glycoconjugates Bioconjug. Chem. 17 493 500 10.1021/bc0502816 1:CAS:528:DC%2BD28XhsFOrtr8%3D 16536482
17. JG Joyce IJ Krauss HC Song DW Opalka KM Grimm DD Nahas MT Esser R Hrin M Feng VY Dudkin M Chastain JW Shiver SJ Danishefsky 2008 An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions Proc. Natl. Acad. Sci. U.S.A. 105 15684 15689 10.1073/pnas.0807837105 1:CAS:528:DC%2BD1cXht1yitrrK 18838688
18. RD Astronomo HK Lee CN Scanlan R Pantophlet CY Huang IA Wilson O Blixt RA Dwek CH Wong DR Burton 2008 A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120 J. Virol. 82 6359 6368 10.1128/JVI.00293-08 1:CAS:528:DC%2BD1cXnslyrurw%3D 18434393 (Pubitemid 351875114)
19. YM Chabre R Roy 2008 Recent trends in glycodendrimer syntheses and applications Curr. Top. Med. Chem. 8 1237 1285 10.2174/156802608785848987 1:CAS:528:DC%2BD1MXisFGgtrw%3D 18855708
20. Boas, U., Christensen, J.B., Heegaard, P.M.H. Dendrimers in medicine and biotechnology. In: New Molecular tools, pp. 56-61. Royal Society of Chemistry, London (UK) (2006)
21. G Giannini R Rappuoli G Ratti 1984 The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197 Nucleic Acids Res. 12 4063 4069 10.1093/nar/12.10.4063 1:STN:280:DyaL2c3itFentg%3D%3D 6427753
22. M Broker PM Dull R Rappuoli P Costantino 2009 Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages Vaccine 27 5574 5580 10.1016/j.vaccine.2009.07.036 19619500
23. LA Jackson RM Jacobson KS Reisinger A Anemona LE Danzig PM Dull 2009 A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents Pediatr. Infect. Dis. J. 28 86 91 10.1097/INF.0b013e31818a0237 19116603
24. A Seubert E Monaci M Pizza DT O'Hagan A Wack 2008 The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells J. Immunol. 180 5402 5412 1:CAS:528:DC%2BD1cXkt1arsbc%3D 18390722
25. B Burke VR Gomez-Roman Y Lian Y Sun E Kan J Ulmer IK Srivastava SW Barnett 2009 Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits Virology 387 147 156 10.1016/j.virol.2009.02.005 1:CAS:528:DC%2BD1MXktF2qu7c%3D 19249806
26. G Galli D Medini E Borgogni L Zedda M Bardelli C Malzone S Nuti S Tavarini C Sammicheli AK Hilbert V Brauer A Banzhoff R Rappuoli G Del Giudice F Castellino 2009 Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels Proc. Natl. Acad. Sci. U.S.A. 106 3877 3882 10.1073/pnas.0813390106 1:CAS:528:DC%2BD1MXjt1Gksbg%3D 19237568
27. BL Schwartz AL Rockwood RD Smith DA Tomalia R Spindler 2003 Detection of high molecular weight starburst dendrimers by electrospray ionization mass spectrometry. Rapid communications in mass spectrometry Macromolecules. 36 5526 5529 10.1021/ma021540e
28. A Bardotti G Averani F Berti S Berti V Carinci S D'Ascenzi B Fabbri S Giannini A Giannozzi C Magagnoli D Proietti F Norelli R Rappuoli S Ricci P Costantino 2008 Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases Vaccine 26 2284 2296 10.1016/j.vaccine. 2008.01.022 1:CAS:528:DC%2BD1cXls1yqsbw%3D 18378363
29. S Pohlmann F Baribaud B Lee GJ Leslie MD Sanchez K Hiebenthal-Millow J Munch F Kirchhoff RW Doms 2001 DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus J. Virol. 75 4664 4672 10.1128/JVI.75.10.4664-4672.2001 1:STN:280:DC%2BD3M3it1ehsg%3D%3D 11312337 (Pubitemid 32381508)
30. M Shan PJ Klasse K Banerjee AK Dey SP Iyer R Dionisio D Charles L Campbell-Gardener WC Olson RW Sanders JP Moore 2007 HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells PLoS Pathog. 3 e169 10.1371/journal.ppat.0030169 17983270 (Pubitemid 350291601)
31. CA Bewley S Otero-Quintero 2001 The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120 J. Am. Chem. Soc. 123 3892 3902 10.1021/ja004040e 1:CAS:528:DC%2BD3MXitlynsLs%3D 11457139 (Pubitemid 32899476)
32. JM Binley T Wrin B Korber MB Zwick M Wang C Chappey G Stiegler R Kunert S Zolla-Pazner H Katinger CJ Petropoulos DR Burton 2004 Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies J. Virol. 78 13232 13252 10.1128/JVI.78.23.13232-13252. 2004 1:CAS:528:DC%2BD2cXhtVaqtbfL 15542675 (Pubitemid 39507829)
33. CN Scanlan GE Ritchie K Baruah M Crispin DJ Harvey BB Singer L Lucka MR Wormald P Wentworth Jr N Zitzmann PM Rudd DR Burton RA Dwek 2007 Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody J. Mol. Biol. 372 16 22 10.1016/j.jmb.2007.06.027 1:CAS:528:DC%2BD2sXovFeru7s%3D 17631311 (Pubitemid 47225174)
34. F Mawas M Peyre AS Beignon L Frost G Del Giudice R Rappuoli S Muller D Sesardic CD Partidos 2004 Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross- reacting material 197 vaccine J. Infect. Dis. 190 1177 1182 10.1086/423327 1:CAS:528:DC%2BD2cXosVWmsLk%3D 15319869 (Pubitemid 39186806)
35. D Safari HA Dekker JA Joosten D Michalik AC de Souza R Adamo M Lahmann A Sundgren S Oscarson JP Kamerling H Snippe 2008 Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14 Infect. Immun. 76 4615 4623 10.1128/IAI.00472-08 1:CAS:528:DC%2BD1cXhtF2jtbjJ 18678667
36. A Torosantucci C Bromuro P Chiani F De Bernardis F Berti C Galli F Norelli C Bellucci L Polonelli P Costantino R Rappuoli A Cassone 2005 A novel glyco-conjugate vaccine against fungal pathogens J. Exp. Med. 202 597 606 10.1084/jem.20050749 1:CAS:528:DC%2BD2MXhtVSjs7zN 16147975 (Pubitemid 41258184)
37. A Pashov S MacLeod R Saha M Perry TC VanCott T Kieber-Emmons 2005 Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12 Glycobiology 15 994 1001 10.1093/glycob/cwi083 1:CAS:528:DC%2BD2MXhtVelsb7K 15917430 (Pubitemid 41511493)
38. RW Sanders M Venturi L Schiffner R Kalyanaraman H Katinger KO Lloyd PD Kwong JP Moore 2002 The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120 J. Virol. 76 7293 7305 10.1128/JVI.76.14.7293-7305.2002 1:CAS:528:DC%2BD38XltVylsL0%3D 12072528
39. X Wu T Lipinski FR Carrel JJ Bailey DR Bundle 2007 Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine Org. Biomol. Chem. 5 3477 3485 10.1039/b709912f 1:CAS:528:DC%2BD2sXhtFOjur3N 17943207 (Pubitemid 47587700)
40. RJ Luallen J Lin H Fu KK Cai C Agrawal I Mboudjeka FH Lee D Montefiori DF Smith RW Doms Y Geng 2008 An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies J. Virol. 82 6447 6457 10.1128/JVI.00412-08 1:CAS:528:DC%2BD1cXnslyru7Y%3D 18434410 (Pubitemid 351875122)
41. RJ Luallen H Fu C Agrawal-Gamse I Mboudjeka W Huang FH Lee LX Wang RW Doms Y Geng 2009 A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN J. Virol. 83 4861 4870 10.1128/JVI.02537-08 1:CAS:528:DC%2BD1MXlvVGhsbc%3D 19264785
42. RJ Luallen C Agrawal-Gamse H Fu DF Smith RW Doms Y Geng 2010 Antibodies against Man{alpha}1,2-Man1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains Glycobiology 20 280 286 10.1093/glycob/cwp184 1:CAS:528:DC%2BC3cXhs1Ogurw%3D 19920089
43. RW Scott WE Moore MJ Effland MA Millett 1967 Ultraviolet spectrophotometric determination of hexoses, pentoses, and uronic acids after their reactions with concentrated sulfuric acid Anal. Biochem. 21 68 80 10.1016/0003-2697(67)90084-X 1:CAS:528:DyaF2sXksl2mt74%3D 6062775